Heartflow (NASDAQ:HTFL) CFO Vikram Verghese Sells 3,587 Shares of Stock

Heartflow, Inc. (NASDAQ:HTFL) CFO Vikram Verghese sold 3,587 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $53.15, for a total transaction of $190,649.05. Following the transaction, the chief financial officer owned 149,587 shares of the company’s stock, valued at $7,950,549.05. This trade represents a 2.34% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Vikram Verghese also recently made the following trade(s):

• On Friday, September 18th, Vikram Verghese sold 16,766 shares of Heartflow stock. The shares were sold at an average price of $50.75, for a total transaction of $850,874.50.
• On Thursday, September 17th, Vikram Verghese sold 7,579 shares of Heartflow stock. The shares were sold at an average price of $50.11, for a total transaction of $379,783.69.
• On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The stock was sold at an average price of $50.01, for a total transaction of $33,406.68.
• On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The stock was sold at an average price of $50.24, for a total transaction of $230,752.32.
• On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The stock was sold at an average price of $50.06, for a total transaction of $1,487,482.84.
• On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The shares were sold at an average price of $50.03, for a total value of $332,199.20.
• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The shares were sold at an average price of $49.69, for a total value of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The shares were sold at an average price of $50.60, for a total value of $297,325.60.

Heartflow Stock Performance

NASDAQ HTFL traded down $0.86 during trading on Tuesday, reaching $55.80. 1,276,518 shares of the company’s stock were exchanged, compared to its average volume of 1,595,194. The stock has a market cap of $4.85 billion, a P/E ratio of -30.49 and a beta of 2.50. The company has a 50 day moving average price of $51.45 and a two-hundred day moving average price of $34.75. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $60.56.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. The business had revenue of $64.08 million during the quarter. The firm’s quarterly revenue was up 47.7% on a year-over-year basis. Research analysts forecast that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Heartflow in a report on Wednesday, November 4th. Canaccord Genuity Group boosted their price objective on shares of Heartflow from $45.00 to $56.00 and gave the stock a “buy” rating in a research report on Tuesday, September 22nd. Morgan Stanley upped their target price on shares of Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a report on Friday, August 14th. Benchmark reaffirmed a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. Finally, UBS Group started coverage on shares of Heartflow in a research note on Wednesday, September 9th. They set a “neutral” rating and a $55.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $48.62.

Institutional Trading of Heartflow

A number of large investors have recently made changes to their positions in the company. GAMMA Investing LLC raised its position in Heartflow by 75.1% in the 3rd quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock valued at $32,000 after purchasing an additional 275 shares during the last quarter. Allworth Financial LP boosted its stake in Heartflow by 116.4% during the 3rd quarter. Allworth Financial LP now owns 1,145 shares of the company’s stock worth $57,000 after purchasing an additional 616 shares during the period. IFP Advisors Inc boosted its stake in Heartflow by 844.7% during the 3rd quarter. IFP Advisors Inc now owns 803 shares of the company’s stock worth $40,000 after purchasing an additional 718 shares during the period. Strs Ohio grew its position in Heartflow by 35.3% during the 1st quarter. Strs Ohio now owns 4,600 shares of the company’s stock worth $112,000 after purchasing an additional 1,200 shares during the last quarter. Finally, Integrated Wealth Concepts LLC purchased a new position in Heartflow during the 2nd quarter worth $53,000.

Heartflow Company Profile

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.